Catalyst Wire Dossier Catalyst Wire Dossier

Voltaren Ophtha

diclofenac 0.1%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Voltaren Ophtha, covering 2024-07-01 to 2024-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery [Phase 4]

See pricing